New York City’s Mayor Bloomberg has proposed a ban on the selling of sugar-containing drinks in containers larger than 16 ounces in all types of eating establishments including street vendors, movie theaters, delicatessens and even stadiums. The purpose is to limit sugar intake and theoretically help people lose weight by saving them from themselves. The plan has received mixed reviews with some calling it a “nanny state” action. Also since a ...

Read more...

This series is brought to you by MedPage Today. 1. Sulfonylureas Up Mortality Risk in Diabetes. Diabetic patients treated with three commonly prescribed sulfonylurea drugs had a 50% higher mortality risk compared with patients treated with metformin. 2. Better Medical Homes Come at a Higher Cost. Running a better patient-centered medical home (PCMH) healthcare center may be more costly. 3. Early ADHD Treatment ...

Read more...

This series is brought to you by MedPage Today. 1. Glycemic Control Reduces CV Risk. Diabetes patients who responded to glucose-lowering treatment also improved their risk of adverse cardiovascular outcomes. 2. USPSTF: Screen All Potential Moms for Abuse. All women of childbearing age should be screened for intimate partner violence, with appropriate referrals made for those who have been abused. 3. Targeted Cancer ...

Read more...

This series is brought to you by MedPage Today. 1. Statins Sap Energy, Study Affirms. Statin drugs may leave users -- especially women -- feeling drained and tired on exertion. 2. Belly Fat Loss Best to Halt Diabetes. Although two bariatric surgery techniques resulted in similar weight loss, the one that shaved more belly fat led to a better rate of diabetes remission. 3.
Read more...

This series is brought to you by MedPage Today. 1. No CV or Cancer Risk with Insulin. The longest trial to study insulin has concluded it has a neutral effect on cardiovascular outcomes and cancer incidence. 2. Avandia, Actos May Raise Risk of Macular Edema. The diabetes drugs pioglitazone (Actos) and rosiglitazone (Avandia) appear to substantially boost risk of macular edema in type 2 ...

Read more...

This series is brought to you by MedPage Today. 1. Fish Oil Takes Down Lipids in Diabetics. Diabetics with mixed dyslipidemia who were on statins improved their lipid profiles, without worsening glycemic control, with a novel omega-3 fatty acid drug. 2. Byetta Tops as Add-On Diabetes Therapy. The GLP-1 receptor agonist exenatide (Byetta) was superior to glimepiride (Amaryl) as an add-on therapy once patients ...

Read more...

Now more than ever, the growing consensus among many is that doctors should avoid seeing pharmaceutical sales representatives, otherwise known as drug reps. A position statement from the AAMC, the head organization of all US medical schools and residency programs, recommends that all academic health centers avoid having drug reps on their campuses, hospital and clinics. Many medical institutions including the VA and Kaiser have also enacted similar policies banning ...

Read more...

Propaganda and non-truths abound all around the Internet saying that mobile health apps are everything from a threat to Big Pharma to a way to save billions of dollars in healthcare costs.  There may be a future for mobile apps but a lot of work is yet to be done. Last year I led some market research into mobile apps across all demographic segments and several disease conditions.  While we did ...

Read more...

MKSAP: 22 year old man with type 1 diabetes mellitusTest your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 22-year-old man comes for a routine evaluation. He has a history of type 1 diabetes mellitus and began taking insulin glargine and insulin lispro 8 years ago. Two days ago, he participated in a marathon race. On physical examination, temperature is 36.4 °C (97.5 °F), ...

Read more...

Year: 1979 Setting: George Washington University Hospital Position: Intern In sharing my global health background, I would be remiss if I did not talk about some of my American experience. After all, Washington, D.C., is remote from Palo Alto and Paris! I am in my late 20s and an intern at George Washington University as an exchange student from Brazil. My mentor, Stanley Talpers, MD, has organized a rotating program for the interns, ...

Read more...

Most Popular